Goldman Sachs Future Health Care Eq ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Goldman Sachs Future Health Care Equity ETF GDOC
Morningstar’s Analysis GDOC
Will GDOC outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the GDOC management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of GDOC’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 56.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 13.53 | 3M | Healthcare |
Johnson & Johnson | 8.45 | 2M | Healthcare |
Merck & Co Inc | 6.57 | 1M | Healthcare |
Guardant Health Inc | 5.26 | 1M | Healthcare |
AstraZeneca PLC | 4.65 | 933,594 | Healthcare |
argenx SE ADR | 3.93 | 788,884 | Healthcare |
Intuitive Surgical Inc | 3.84 | 771,162 | Healthcare |
Cencora Inc | 3.53 | 707,872 | Healthcare |
DexCom Inc | 3.47 | 695,605 | Healthcare |
Thermo Fisher Scientific Inc | 3.37 | 675,861 | Healthcare |
United States